A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2026-06-25

Target enrollment:

Participant gender:

The main purpose of this study is to assess the dose-response relationship of maridebart cafraglutide on glucose control compared with placebo.

PHASE2

Amgen